Ligand profile
ZXM
Ligand co-crystallized with this exact protein (Protein Data Bank).
Bound to: KP13_06703 — Carbepenem-hydrolyzing beta-lactamase KPC2
Identifiers
Database identifiers and provenance.
- Ligand ID
ZXM- PDB
5eec- UniProt (this protein)
Q9F663- Target protein
- KP13_06703
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 137.6
- −1 ≤ LogP ≤ 5 -1.22
- MW ≤ 500 Da 324.1
- LogP ≤ 5 -1.22
- H-bond donors ≤ 5 4
- H-bond acceptors ≤ 10 8
- Rotatable bonds ≤ 10 7
- TPSA ≤ 140 Ų 137.6
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
B([C@H](Cn1cc(nn1)C(=O)O)NC(=O)Cc2cccs2)(O)OB([C@H](Cn1cc(nn1)C(=O)O)NC(=O)Cc2cccs2)(O)O
InChI=1S/C11H13BN4O5S/c17-10(4-7-2-1-3-22-7)13-9(12(20)21)6-16-5-8(11(18)19)14-15-16/h1-3,5,9,20-21H,4,6H2,(H,13,17)(H,18,19)/t9-/m0/s1InChI=1S/C11H13BN4O5S/c17-10(4-7-2-1-3-22-7)13-9(12(20)21)6-16-5-8(11(18)19)14-15-16/h1-3,5,9,20-21H,4,6H2,(H,13,17)(H,18,19)/t9-/m0/s1
ZXGRTNOGXAKRBS-VIFPVBQESA-NZXGRTNOGXAKRBS-VIFPVBQESA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ sequence
- Source
- PDB
- Binding sites
- PF00144' 'PF13354
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand ZXM →
- PDB RCSB structure 5eec →
- UniProt UniProt Q9F663 (same protein) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “ZXM”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_06703.
PDB 35
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 100
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).